The Neutrophil-to-Lymphocyte Ratio as a Biomarker in Metastatic Castrate-Sensitive Prostate Cancer Patients Treated with Abiraterone Acetate by Caio Vinícius Suartz, Marie-Laurence Roy, Paul Toren

Subjects: Get full text

Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)—A Potential New Standard of Care by Abhenil Mittal, Srikala S. Sridhar, Michael Ong, Di Maria Jiang

Subjects: “…metastatic castrate sensitive prostate cancer…”
Get full text

Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial by Byung Ha Chung, Jian Huang, Hiroji Uemura, Young Deuk Choi, Zhang-Qun Ye, Hiroyoshi Suzuki, Taek Won Kang, Da-Lin He, Jae Young Joung, Sabine D Brookman-May, Sharon McCarthy, Amitabha Bhaumik, Anildeep Singh, Suneel Mundle, Simon Chowdhury, Neeraj Agarwal, Ding-Wei Ye, Kim N Chi, Hirotsugu Uemura

Subjects: “…apalutamide; asia; event-driven analysis; metastatic castration-sensitive prostate cancer; overall survival…”
Get full text

Efficacy of enzalutamide in patients with metastatic hormone-sensitive and castration-refractory prostate cancer: authors’ experience by T. V. Ustinova, L. V. Bolotina, A. A. Paichadze, A. A. Kachmazov, A. A. Fedenko, A. D. Kaprin

Subjects: Get full text

Current status and future perspective on the management of metastatic castration-sensitive prostate cancer by Leandro Blas, Masaki Shiota, Masatoshi Eto

Subjects: Get full text

Estimation of Overall Survival with Subsequent Treatment Effect by Applying Inverse Probability of Censoring Weighting in the LATITUDE Study by Yosuke Koroki, Masataka Taguri, Nobuaki Matsubara, Karim Fizazi

Subjects: Get full text

Prognostic value of prostate-specific antigen in advanced prostate cancer treated with androgen deprivation therapy and abiraterone by L. Lou, J. Wei, S. Ma, W. Chen, X.-L. Cao, F.-H. Sun

Subjects: Get full text

AKR1C3-negative high-risk metastatic castration-sensitive prostate cancer has long-term response to first-line treatment with abiraterone: Four case reports by Tsuyoshi Yoshizawa, Yoko Nakanishi, Daisuke Obinata, Kenya Yamaguchi, Shinobu Masuda, Satoru Takahashi

Subjects: “…High-risk metastatic castration-sensitive prostate cancer…”
Get full text

Population-Based Study of Docetaxel or Abiraterone Effectiveness and Predictive Markers of Progression Free Survival in Metastatic Castration-Sensitive Prostate Cancer by Juan Briones, Maira Khan, Amanjot K. Sidhu, Liying Zhang, Martin Smoragiewicz, Martin Smoragiewicz, Urban Emmenegger, Urban Emmenegger, Urban Emmenegger, Urban Emmenegger

Subjects: “…metastatic castration sensitive prostate cancer (mCSPC)…”
Get full text

Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan by Takahiro Kimura, Noriko Takahashi, Keiko Asakawa, Atsushi Saito, Takeshi Mitomi, Takumi Lee, Mika Matsumura

Subjects: Get full text